Latest Announcements

NDR Auto Components Ltd has announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The company has reported a net profit of Rs. 1,472.18 lakhs for the quarter, with a basic earning per share of Rs. 6.19. The company has also approved the grant of 66,641 stock options to eligible employees and has invested Rs. 8 crore in its wholly-owned subsidiary company.

NDR Auto Components Limited has submitted its unaudited standalone financial results for the quarter ended June 30, 2026. The results show a revenue from operations of Rs. 22,359.85 lakhs, a net profit of Rs. 1,472.18 lakhs, and an EPS of Rs. 6.19.

Power Mech Projects Limited has announced its Q1 FY 2027 earnings, with revenue growing 26% YoY to INR 1,624 Cr, EBITDA at INR 176 Cr, and order inflows of INR 1,864 Cr. The company has an order backlog of INR 55,398 Cr and is focused on disciplined execution, improving profitability, and executing the order pipeline across core and emerging businesses.

Sanofi India Limited has announced its unaudited financial results for the quarter and half year ended 30th June 2026, with a strong momentum in the diabetes business, driven by double-digit growth in the domestic market, powered by innovative portfolio, Toujeo and Soliqua. The company has also reported a 2% growth in quarter two over last year's quarter two, based on the continued ROI from partnership with Emcure and Cipla.

Power Mech Projects Ltd has announced its Q1 FY 2027 earnings, with revenue of INR 1,624 Cr, a 26% YoY growth, and EBITDA of INR 176 Cr. The company secured order inflows of INR 1,864 Cr, including marquee wins from JSW, Adani, and MMMOCL. The order backlog stands at INR 55,398 Cr, providing 2+ years of revenue visibility.

Upsurge Investment & Finance Ltd's board approved unaudited financial results for Q1 FY2026-27 and declared an interim dividend of 5% for FY2026-27.

Singer India Ltd has announced the voting results of its 48th Annual General Meeting, with all resolutions passed. The company declared a final dividend on equity shares for the financial year ended March 31, 2026, and appointed a new director.

Sanofi India Ltd announced unaudited financial results for the quarter and half year ended 30th June 2026, with a double-digit growth of 14% in the diabetes business, driven by innovative portfolio Toujeo and Soliqua. The company maintained a market leadership position with a 47% market share by value and volume acceleration of 6% with Lantus. The results were presented during an investor conference call on August 5, 2026.

Kirloskar Brothers Limited has reported Q1 FY '27 results, with consolidated revenue at Rs.11,049 million, a 13% year-on-year growth, driven by robust demand across its diverse product portfolio and sustained momentum in both domestic and international markets.

Kirloskar Brothers Ltd. has announced its unaudited financial results for Q1 FY '27, with a 13% year-on-year growth in consolidated revenue to Rs.11,049 million. The company's consolidated EBITDA for the quarter stood at Rs.1,306 million, with a 2% year-on-year growth and an EBITDA margin of 11.8%. The company also recorded a 4% year-on-year growth in consolidated order intake to Rs.13,954 million.

Alembic Pharmaceuticals Ltd reported a strong Q1 FY27 with 26% YoY revenue growth, driven by growth across all major businesses, including a 7% growth in India branded business, 37% growth in International Generics, and 33% growth in API business. The company's external environment remains competitive with pricing pressure, regulatory expectations, and geopolitical uncertainties.

Alembic Pharmaceuticals Limited has reported a strong Q1 FY27 with 26% year-on-year revenue growth, driven by growth across all major businesses, including a 7% growth in India branded business, 37% growth in International Generics, and 33% growth in API business. The company has also strengthened its execution leadership with the appointment of Mr. Ramesh Juneja as Sales and Marketing Head for Human Health business.

Lyka Labs Limited has announced its unaudited financial results for the first quarter ended June 30, 2026, with a standalone net total income up 42.67% at Rs. 4272.79 Lacs and a consolidated net total income up 26.95% at Rs. 4272.79 Lacs.

Emami Ltd reported Q1 FY27 earnings, with consolidated revenue growing 15% to INR1,039 crores, driven by 20% growth in domestic business and 12% growth on a like-to-like basis. The company is transitioning to category-wise reporting and has seen strong performance in hair and scalp care, healthcare, and strategic investment portfolio.

Lyka Labs Ltd has announced its unaudited financial results for Q1 FY27, showing a 42.67% increase in standalone net total income and a 159.04% increase in standalone net profit.

Gulf Oil Lubricants India Limited's Q1 FY27 earnings conference call transcript has been released, with the company's management discussing their strong revenue and EBITDA growth, despite a volatile macro environment and supply chain disruptions.

Gulf Oil Lubricants India Ltd reported Q1 FY27 earnings, with revenue crossing INR 1,300+ crores, a 30% increase from the previous quarter. EBITDA and profits also showed significant growth. The company managed to maintain supply security despite the West Asia crisis and volatile macro environment, and won new customers in various segments.

Kwality Pharmaceuticals Ltd has raised its FY27 guidance for revenue and profitability, citing strong execution and clear visibility. The company has also highlighted its expertise in complex formulation, research, and manufacturing, with a broad and diverse product offering across 25+ therapeutic areas. The announcement includes forward-looking statements and cautions against relying on them for future performance.

Mold-Tek Technologies Limited has informed the Exchange about the transcript of the Conference Call for Investors held on August 06, 2026 to discuss Q1FY27 results. The company has come out with a stellar performance by increasing revenues, improving operational efficiencies, and controlling costs, resulting in a 4x jump in profitability compared to Q4 and 12x compared to Q1 last year. The future is expected to be bright with more automation and increased demand for services.

Metro Brands Limited has informed the Exchange about the transcript of the investor call on unaudited financial results for the quarter ended June 30, 2026. The company posted a 14% growth in its standalone business, along with a 9% growth in EBITDA, leading to a 13% PAT. The company's gross margins matched its highest gross margin for the past 5 quarters, coming in at almost 60%. The company opened 13 new stores and closed 4 stores for a net of 9 stores.